These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 20120756)

  • 1. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA; Mearag I; Saleh NM; Saied A
    J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological study of apparently normal skin of patients with leprosy.
    El-Darouti MA; Hussein S; Marzouk SA; Nabil N; Hunter NS; Mahgoub D; El-Eishi NH; Abdel-Halim MR
    Int J Dermatol; 2006 Mar; 45(3):292-6. PubMed ID: 16533232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
    Costa MB; Cavalcanti Neto PF; Martelli CM; Stefani MM; Maceira JP; Gomes MK; Schettini AP; Rebello PF; Pignataro PE; Ueda ES; Narahashi K; Scollard DM
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era.
    Singal A; Sonthalia S; Pandhi D
    Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactions in borderline leprosy.
    Ramu G; Desikan KV
    Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
    Kumar A; Girdhar A; Girdhar BK
    Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of diagnostic role of in situ PCR on slit-skin smears in pediatric leprosy.
    Kamal R; Natrajan M; Katoch K; Katoch VM
    Indian J Lepr; 2010; 82(4):195-200. PubMed ID: 21434596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy.
    Kamal R; Natrajan M; Katoch K; Arora M
    Indian J Lepr; 2012; 84(4):287-306. PubMed ID: 23720894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multibacillary nerve histology in clinically diagnosed borderline tuberculoid leprosy patients.
    Ebenezer GJ; Suneetha S; Mohandas R; Arunthathi S
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):311-5. PubMed ID: 8862266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
    Jain M; Singh N; Bhatia A; Arora VK
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological changes in the arrector pili muscle of normal appearing skin in leprosy patients.
    Budhiraja V; Rastogi R; Khare S; Khare A; Krishna A
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e70-2. PubMed ID: 20207571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of skin and nerve and clinical classification in leprosy patients.
    Lakshmi TS; Rao PN; Krishna AV; Kumar EC
    Indian J Lepr; 1996; 68(3):258-60. PubMed ID: 8889614
    [No Abstract]   [Full Text] [Related]  

  • 16. Utility of fine-needle aspiration cytology in the classification of leprosy.
    Rao IS; Singh MK; Gupta SD; Pandhi RK; Kapila K
    Diagn Cytopathol; 2001 May; 24(5):317-21. PubMed ID: 11335960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinico-pathological study of macular lesions in leprosy.
    Kar PK; Arora PN; Ramasastry CV; Sayal SK; Dhaka RS
    Indian J Lepr; 1994; 66(4):435-42. PubMed ID: 7714352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
    Mathew D; Kishore BN; Shwethadri GK; Sukumar ; Shetty NJ
    Indian J Lepr; 2004; 76(1):11-8. PubMed ID: 15527055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.